MedTrace Logo

Titan Spine Endoskeleton TT/TO Study

NCT03910309 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-04-10

No results posted yet for this study

Summary

This is a prospective, multi-center controlled observational clinical study. All subjects will receive Titan Endoskeleton TT/TO acid etched titanium implant for the planned procedure. Each site will have a predetermined bonegraft extender to be used in all enrolled subjects at that site.

Conditions

  • Degenerative Disc Disease, Spondylolisthesis

Interventions

DEVICE

TLIF with Titan TT/TO interbody cage

fusion surgery

Sponsors & Collaborators

  • Titan Spine

    lead INDUSTRY

Principal Investigators

  • Reginald Davis, MD · Laser Spine Institute

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-07-31
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03910309 on ClinicalTrials.gov